Livvlife Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 1.65 Cr
- Revenue Growth %
- Profit Growth 34.33%
- Ebitda 34.33%
- Net Worth -16.52%
- Total Assets -0.04%
About Livvlife Pharmaceuticals
Livvlife Pharmaceuticals Limited (LPL) is a Public Limited Indian Non-Government Company incorporated in India on 08 October 2007 and has a history of 17 years and four months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Livlife Pharmaceuticals Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Deepak Agarwal, Madhu Agarwal, and Alok Agarwal serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232MH2007PLC174804
-
Company No.
174804
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
08 Oct 2007
-
Date of AGM
30 Sep 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Livvlife Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Agarwal
|
Director | 08-Oct-2007 | Current |
|
Madhu Agarwal
|
Director | 08-Oct-2007 | Current |
|
Alok Agarwal
|
Director | 07-Jan-2013 | Current |
Financial Performance of Livvlife Pharmaceuticals.
Livvlife Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 34.33% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Livvlife Pharmaceuticals?
In 2017, Livvlife Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹16.50 M
Charges Breakdown by Lending Institutions
- Bank Of India : 1.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2010 | Bank Of India | ₹1.65 Cr | Satisfied |
How Many Employees Work at Livvlife Pharmaceuticals?
Unlock and access historical data on people associated with Livvlife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Livvlife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Livvlife Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
